VivoSim Labs (VIVS) Liabilities and Shareholders Equity (2011 - 2026)

VivoSim Labs has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $3.8 million in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 67.88% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $27.9 million, a 25.11% decrease from a year earlier, with the FY2026 full-year figure at $7.4 million, down 49.58% from the prior year.
• Liabilities and Shareholders Equity was $3.8 million for Q2 2026 at VivoSim Labs, down from $7.4 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $33.3 million in Q1 2022, with the low at $3.8 million in Q4 2024.
• Average Liabilities and Shareholders Equity over 5 years is $14.0 million, with a median of $10.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity tumbled 68.74% in 2024, then soared 130.74% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $25.1 million in 2022, then tumbled by 64.59% to $8.9 million in 2023, then slumped by 56.72% to $3.8 million in 2024, then soared by 81.06% to $7.0 million in 2025, then plunged by 44.73% to $3.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $3.8 million (Q2 2026), $7.4 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.